كندا - الإنجليزية - Health Canada

mylan pharmaceuticals ulc - vancomycin (vancomycin hydrochloride) - powder for solution - 10g - vancomycin (vancomycin hydrochloride) 10g - glycopeptides

كندا - الإنجليزية - Health Canada

hikma canada limited - vancomycin (vancomycin hydrochloride) - powder for solution - 5g - vancomycin (vancomycin hydrochloride) 5g

كندا - الإنجليزية - Health Canada

hikma canada limited - vancomycin (vancomycin hydrochloride) - powder for solution - 10g - vancomycin (vancomycin hydrochloride) 10g

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

generics (uk) limited - vancomycin hydrochloride - pdr/conc/soln for infus - 1000 milligram - vancomycin - antibacterials for systemic use: glycopeptide antibacterials - it is used for severe infections, caused by gram-positive bacteria susceptible to vancomycin which cannot be treated with or failed to respond or are resistant to other antibiotics such as penicillins and cephalosporins.

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

generics (uk) limited - vancomycin hydrochloride - pdr/conc/soln for infus - 500 milligram - vancomycin - antibacterials for systemic use: glycopeptide antibacterials - it is used for severe infections, caused by gram-positive bacteria susceptible to vancomycin which cannot be treated with or failed to respond or are resistant to other antibiotics such as penicillins and cephalosporins

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

xellia pharmaceuticals aps - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin 5 g in 100 ml - vancomycin hydrochloride for injection, usp is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (β-lactam-resistant) staphylococci. it is indicated for penicillin-allergic patients, for patients who cannot receive or who have failed to respond to other drugs, including the penicillins or cephalosporins, and for infections caused by vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. vancomycin hydrochloride for injection, usp is indicated for initial therapy when methicillin-resistant staphylococci are suspected, but after susceptibility data are available, therapy should be adjusted accordingly. vancomycin hydrochloride for injection, usp is effective in the treatment of staphylococcal endocarditis. its effectiveness has been documented in other infections due to staphylococci, including septicemia, bone infections, lower respiratory tract infections, skin and skin structure infections. when staphylococcal infecti

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

mylan institutional llc - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin 5 g in 100 ml - vancomycin hydrochloride for injection, usp is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (β-lactam-resistant) staphylococci. it is indicated for penicillin-allergic patients, for patients who cannot receive or who have failed to respond to other drugs, including the penicillins or cephalosporins, and for infections caused by vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. vancomycin hydrochloride for injection, usp is indicated for initial therapy when methicillin-resistant staphylococci are suspected, but after susceptibility data are available, therapy should be adjusted accordingly. vancomycin hydrochloride for injection, usp is effective in the treatment of staphylococcal endocarditis. its effectiveness has been documented in other infections due to staphylococci, including septicemia, bone infections, lower respiratory tract infections, skin and skin structure infections. when staphylococcal infecti

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

rebel distributors corp - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin 500 mg in 10 ml - vancomycin is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci. it is indicated for penicillin-allergic patients, for patients who cannot receive or who have failed to respond to other drugs, including the penicillins or cephalosporins, and for infections caused by vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. vancomycin is indicated for initial therapy when methicillin-resistant staphylococci are suspected, but after susceptibility data are available, therapy should be adjusted accordingly. vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis. its effectiveness has been documented in other infections due to staphylococci, including septicemia, bone infections, lower respiratory tract infections, and skin and skin-structure infections. when staphylococcal infections are localized and purulent, antibiotics are used as adjuncts to appropriat

إسرائيل - الإنجليزية - Ministry of Health

david margalit & co.ltd - vancomycin as hydrochloride - powder for concentrate for solution for iv infusion/ oral solution - vancomycin as hydrochloride 1000 mg - vancomycin - vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-iactam-resistant) staphylococci. it is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs.vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - structure infection and bone infections. antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. for endocarditis due to streptococcus viridans or streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside. vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg enterococcus fecalis). vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. in early-onset prosthetic valve endocarditis caused by staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. oral therapy:vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated pseudomembrannous colitis due to staphylococcus enterocolitis and clostridium difficile. vancomycin hydrochloride is not effective orally when administered for other types of infection.

إسرائيل - الإنجليزية - Ministry of Health

david margalit & co.ltd - vancomycin as hydrochloride - powder for concentrate for solution for iv infusion/ oral solution - vancomycin as hydrochloride 500 mg - vancomycin - vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-iactam-resistant) staphylococci. it is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs.vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - structure infection and bone infections. antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. for endocarditis due to streptococcus viridans or streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside. vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg enterococcus fecalis). vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. in early-onset prosthetic valve endocarditis caused by staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. oral therapy:vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated pseudomembrannous colitis due to staphylococcus enterocolitis and clostridium difficile. vancomycin hydrochloride is not effective orally when administered for other types of infection.